Nobel prize winner Paul Ehrlich in 1900 was the first to come up with the concept of the magic bulleta drug to specifically target a disease-causing factor. At the time, research into antibodies was not sophisticated enough to allow them to fulfill that role, but a lot of progress has been made since then. This illustrated timeline provides a look back at the major innovations that allowed antibody therapeutics to become the multi-billion dollar industry that it is today. Keystone research discoveries and drug approvals from the first images of an antibody's molecular structure in 1959 to the release of the first antibody biosimilar in 2016 are highlighted. 

Download Now

    Please fill out the information below to download the content. If you are already registered, or have requested a quote before, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.